Home > Subjects > Medical > COVID-19 in a Hemodialysis Patient

COVID-19 in a Hemodialysis Patient

A man in his 50s is getting support hemodialysis introduced to the crisis division with a 7-day history of a non-profitable hack. His clinical history included kidney disappointment because of diabetes kept up on the threefold week by week in-focus hemodialysis, hypertension, and constant hepatitis B infection (HBV) disease. An epidemiological review indicated that he headed to Wuhan in mid-January 2020, visited his family members, and drove back to Zhongshan City of Guangdong area in China multi-week later. He was admitted to the medical clinic fourteen days after the fact with hypoxemia (blood oxygen immersion 90% on room air) without fever or myalgia. Physical assessment results indicated a temperature of 36.9°C, a pulse of 184/107 mm Hg, a pulse of 74 beats/min, and two-sided typical lung respiratory sounds. Research centre tests demonstrated a white platelet check of 3.38×10⁹ per L with 77.5% neutrophils, 15.7% lymphocytes, and 0% eosinophils. C-responsive protein (CRP) and procalcitonin (PCT) were 40.1 mg/L and 0.73 ng/mL, individually. Liver capacity and cardiovascular compounds were inside the normal range. Chest registered tomography (CT) indicated reciprocal numerous ground-glass opacities (Figure 1). The Chinese Guangdong Center for Disease Prevention and Control (CDC) detailed SARS-CoV-2 infection nucleic basic analyses were certain in throat swab tests multiple times. Given epidemiological attributes and these discoveries, we analyzed COVID-19 pneumonia.

COVID-19 in a Hemodialysis Patient

When COVID-19 pneumonia was analyzed, the patient was moved to a strength emergency clinic and got hemodialysis in a live with disengagement offices assigned for COVID-19 patients. Albeit all hemodialysis patients wear a face cover during dialysis, the other 42 patients who had a potential presentation to COVID-19 due to getting dialysis in a similar room were likewise moved to the disengagement ward of the strength emergency clinic with regular dialysis for 14 days. These hemodialysis patients were tried for SARS-CoV-2 infection nucleic corrosive at affirmation and 14 days, staying negative. As a result of all-inclusive precautionary measures taken by the clinical staff, the staff were tried for SARS-CoV-2 infection nucleic corrosive negative, and not detached.

The patient was treated with oxygen support through a nasal cannula, regular hemodialysis, antihypertensive meds, moxifloxacin (400 mg day by day), and lopinavir/ritonavir (two tablets twice every day) antiviral treatment. The potential reactions of lopinavir/ritonavir, for example, sickness, loose bowels, and infrequent tipsiness were not seen during surgery. Eight days of treatment, the SARS-CoV-2 infection nucleic analyses were negative in throat swab tests twice, the hack had improved, and research Centre test results and chest CT pictures had improved (Figure 1). The patient was released from the emergency clinic (Tang, Li et al. 2020).


In outline, we portray hemodialysis quiet with COVID-19 pneumonia. This specific patient had a generally mellow course, regardless of numerous comorbid conditions counting incessant hepatitis B and type 2 diabetes. With suitable disease control measures, the staff who thought about this patient were not tainted. Lopinavir/ritonavir was utilized in this patient, regardless of whether this brought about less serious ailment stays unsure yet warrants further examination. In conclusion, through thorough triage measures, we had the option to restrain the transmission of disease to different patients (Tang, Li et al. 2020).


Related Posts

Leave a Comment